AMN Healthcare Q4 2020 Earnings Report
Key Takeaways
AMN Healthcare announced Q4 2020 results with revenue of $631 million, up 8% year-over-year. GAAP EPS was $0.19, and adjusted EPS was $1.00. The company experienced record demand for nurse and allied staffing and significant growth in locum tenens and interim leadership during the quarter. All three reportable segments exceeded revenue guidance.
AMN transformed its business to respond to pandemic challenges and evolved its commitment to equality and social justice.
The AMN team extended core solutions and created new, technology-enabled services to help healthcare organizations deal with unprecedented volatility in labor demand.
Full year revenue reached a record high in 2020 with 2% organic growth despite disruption to many of our businesses from the pandemic.
All three reportable segments exceeded revenue guidance in the fourth quarter and carried strong momentum into 2021.
AMN Healthcare
AMN Healthcare
AMN Healthcare Revenue by Segment
Forward Guidance
AMN Healthcare projects revenue between $800 and $820 million for Q1 2021, with a gross margin between 31.5% and 32.0% and an adjusted EBITDA margin between 14.3% and 14.7%. They are projecting 33-36% year-over-year revenue growth in the first quarter of 2021.
Positive Outlook
- Consolidated revenue $800 - $820 Million
- Gross margin 31.5% - 32.0%
- SG&A as percentage of revenue 18.3% - 18.6%
- Operating margin 10.3% - 10.7%
- Adjusted EBITDA margin 14.3% - 14.7%